NYU Tandon-led team crosses barrier needed to deliver drugs at the cellular level and to engineer tissue
Disabling a single, apparently noncritical protein in cells may foil replication of the viruses that cause half of all common colds, polio and other diseases, according to researchers at Stanford and UCSF.
In a surprise finding, UT Southwestern researchers report that lowering levels of the hormone leptin can reduce obesity, overeating, and the insulin resistance tied to diabetes – and they have found an antibody that can do that.
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
The normal human gut microbiome is a flourishing community of microorganisms, some of which can affect the human immune system.